SCHEMBL16682194

SCHEMBL16682194

CC(C)(C)C(=O)NCc1ccc(Cl)c(/C=C/C(=O)c2ccc(Cl)c(Cl)c2)c1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ CXCL12 P48061 1/20 0.39
▸ HPGD P15428 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ EPHX2 P34913 6/20 0.38
▸ NR1H4 Q96RI1 5/20 0.38
▸ MAPT P10636 2/20 0.37
▸ MDM4 O15151 1/20 0.37
▸ MDM2 Q00987 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PTGES O14684 2/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16671628 1.00 ALOX5 (0.40) ALOX5PTGS2CXCL12HPGDLMNA
SCHEMBL16670728 0.92 DPP4 (0.39) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16670731 0.92 DPP4 (0.39) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16671832 0.91 DPP4 (0.38) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16671833 0.91 DPP4 (0.38) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16671059 0.90 DDR1 (0.38) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16671060 0.90 DDR1 (0.38) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16682136 0.88 CYP1A1 (0.46) HPGDLMNAALOX12ATMSMN1; SMN2
SCHEMBL16670998 0.79 CA1 (0.39) EPHX2NR1H4PTGESHDAC6
SCHEMBL16682176 0.74 DDR1 (0.35) EPHX2NR1H4PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015059618-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-30 — — WO disclosed
Send feedback